Carregant...
Drugs against SARS‐CoV‐2: What do we know about their mode of action?
The health emergency caused by the recent Covid‐19 pandemic highlights the need to identify effective treatments against the virus causing this disease (SARS‐CoV‐2). The first clinical trials have been testing repurposed drugs that show promising anti‐SARS‐CoV‐2 effects in cultured cells. Although m...
Guardat en:
| Publicat a: | Rev Med Virol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7435512/ https://ncbi.nlm.nih.gov/pubmed/32779326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rmv.2143 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|